Device
WalkAide
WalkAide is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
2
50%
Ph phase_4
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
unknown2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
unknown250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_1
Evaluation of the Increase of the Driving Speed With Walkaide® Medical Device
NCT02639689
unknownphase_4
Effects of Functional Electrical Stimulation on Gait in Children With Cerebral Palsy
NCT02462018
completednot_applicable
WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients
NCT01087957
completednot_applicable
Efficacy of the WalkAide and AFOs for CVA
NCT00216320
Clinical Trials (4)
Showing 4 of 4 trials
NCT02639689Phase 1
Evaluation of the Increase of the Driving Speed With Walkaide® Medical Device
NCT02462018Phase 4
Effects of Functional Electrical Stimulation on Gait in Children With Cerebral Palsy
NCT01087957Not Applicable
WalkAide Compared to Ankle-Foot Orthosis (AFO) in Stroke Patients
NCT00216320Not Applicable
Efficacy of the WalkAide and AFOs for CVA
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4